Hendra and Nipah viruses: Why are they so deadly?

Current Opinion in Virology

Volumn 2, Issue 3, 2012, Pages 242-247

  Marsh, Glenn A ^a   Wang, Lin Fa ^a  

^a CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; RIBAVIRIN; VIRUS VACCINE;

HENDRA VIRUS; HUMAN; IMMUNOPATHOGENESIS; NIPAH VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

HENDRA VIRUS; HENIPAVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; NIPAH VIRUS; VIRULENCE; VIRULENCE FACTORS;

EID: 84862868553     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2012.03.006     Document Type: Review

References (68)

1. Eaton BT, Mackenzie JS, Wang LF: Henipaviruses. In Fields Virology, edn 5. Edited by Knipe DM, Howley PM.Lippincott, Williams and Wilkins; 2007:1587-1600.
2. Eaton BT, Broder CC, Middleton D, Wang LF: Hendra and Nipah viruses:differentanddangerous. Nat RevMicrobiol2006,4:23-35.
3. Wang LF, Michalski WP, Yu M, Pritchard LI, Crameri G, Shiell B, Eaton BT: A novel P/V/C gene in a new member of the Paramyxoviridae family, which causes lethal infection in humans, horses, and other animals. J Virol 1998, 72:1482-1490. (Pubitemid 28116936)
4. Murray K, Selleck P, Hooper P, Hyatt A, Gould A, Gleeson L, Westbury H, Hiley L, Selvey L, Rodwell B et al.: A morbillivirus that caused fatal disease in horses and humans. Science 1995, 268:94-97.
5. Young PL, Halpin K, Selleck PW, Field H, Gravel JL, Kelly MA, Mackenzie JS: Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. Emerg Infect Dis 1996, 2:239-240. (Pubitemid 126444995)
6. Anonymous: Hendra virus, Equine - Australia (18): (Queensland), Canine. ProMED-mail 2011. July 7, 2011, archive no. 20110727.2257 First report of Hendra virus infection in canine in Australia.
7. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W et al.: Nipah virus: a recently emergent deadly paramyxovirus. Science 2000, 288:1432-1435. (Pubitemid 30366331)
8. Weingartl HM, Berhane Y, Czub M: Animal models of henipavirus infection: a review. Vet J 2009, 181:211-220.
9. Selvey LA, Wells RM, McCormack JG, Ansford AJ, Murray K, Rogers RJ, Lavercombe PS, Selleck P, Sheridan JW: Infection of humans and horses by a newly described morbillivirus. Med J Aust 1995, 162:642-645.
10. Murray K, Rogers R, Selvey L, Selleck P, Hyatt A, Gould A, Gleeson L, Hooper P, Westbury H: A novel morbillivirus pneumonia of horses and its transmission to humans. Emerg Infect Dis 1995, 1:31-33.
11. Marsh GA, Todd S, Foord A, Hansson E, Davies K, Wright L, Morrissy C, Halpin K, Middleton D, Field HE et al.: Genome sequence conservation of Hendra virus isolates during spillover to horses, Australia. Emerg Infect Dis 2010, 16:1767-1769. Demonstrates the sequence conservation of different Hendra virus strains that had spilled over into horses at different locations from 2006 to 2008.
12. Smith I, Broos A, de Jong C, Zeddeman A, Smith C, Smith G, Moore F, Barr J, Crameri G, Marsh G et al.: Identifying Hendra virus diversity in pteropid bats. PLoS One 2011, 6:e25275. Demonstrates that Hendra virus in the natural host, the fruit bat, has a genome conservation similar to that observed in equine isolates.
13. Anonymous: Hendra virus, Equine - Australia (29): (Queensland, New South Wales). ProMED-mail 2011. October 14, 2011, archive no. 20111014.3075.
14. Anonymous: Hendra virus, Equine - Australia: (Queensland). ProMED-mail 2012. January 6, 2012, archive no. 20120106.1001359.
15. Playford EG, McCall B, Smith G, Slinko V, Allen G, Smith I, Moore F, Taylor C, Kung YH, Field H: Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg Infect Dis 2010, 16:219-223.
16. O'Sullivan JD, Allworth AM, Paterson DL, Snow TM, Boots R, Gleeson LJ, Gould AR, Hyatt AD, Bradfield J: Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet 1997, 349:93-95. (Pubitemid 27023426)
17. Baldock FC, Douglas IC, Halpin K, Field H, Young PL, Black PF: Epidemiological investigations into the 1994 Equine morbillivirus outbreaks in Queensland, Australia. Sing Vet J 1996, 20:57-61.
18. Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Zaki SR, Paul G, Lam SK, Tan CT: Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet 1999, 354:1257-1259. (Pubitemid 29469355)
19. Chua KB: Nipah virus outbreak in Malaysia. J Clin Virol 2003, 26:265-275.
20. Paton NI, Leo YS, Zaki SR, Auchus AP, Lee KE, Ling AE, Chew SK, Ang B, Rollin PE, Umapathi T et al.: Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet 1999, 354:1253-1256. (Pubitemid 29469354)
21. Luby SP, Hossain MJ, Gurley ES, Ahmed BN, Banu S, Khan SU, Homaira N, Rota PA, Rollin PE, Comer JA et al.: Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis 2009, 15:1229-1235. Highlights the importance of the role of human-to-human transmission in the spread of Nipah virus in Bangladesh.
22. Anonymous: Nipah Encephalitis, Human - Bangladesh (05): (Rangpur). ProMED-mail 2011. March 8, 2011, archive no. 20110308.0756.
23. Luby SP, Gurley ES, Hossain MJ: Transmission of human infection with Nipah virus. Clin Infect Dis 2009, 49:1743-1748.
24. Mounts AW, Kaur H, Parashar UD, Ksiazek TG, Cannon D, Arokiasamy JT, Anderson LJ, Lye MS: A cohort study of health care workers to assess nosocomial transmissibility of Nipah virus, Malaysia, 1999. J Infect Dis 2001, 183:810-813. (Pubitemid 32171757)
25. Montgomery JM, Hossain MJ, Gurley E, Carroll GD, Croisier A, Bertherat E, Asgari N, Formenty P, Keeler N, Comer J et al.: Risk factors for Nipah virus encephalitis in Bangladesh. Emerg Infect Dis 2008, 14:1526-1532.
26. Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, Wong KT, Abdullah BJ, Chua KB, Lam SK: Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med 2000, 342:1229-1235. (Pubitemid 30235951)
27. Chong HT, Kunjapan SR, Thayaparan T, Tong JG, Petharunam V, Jusoh MR, Tan CT: Nipah encephalitis outbreak in Malaysia, clinical features in patients from Seremban. Neurol J Southeast Asia 2000, 5:61-67.
28. Hossain MJ, Gurley ES, Montgomery JM, Bell M, Carroll DS, Hsu VP, Formenty P, Croisier A, Bertherat E, Faiz MA et al.: Clinical presentation of Nipah virus infection in Bangladesh. Clin Infect Dis 2008, 46:977-984. (Pubitemid 351589860)
29. Chong HT, Hossain MJ, Tan CT: Differences in epidemiologic and clinical features of Nipah virus encephalitis between the Malaysian and Bangladesh outbreaks. Neurol Asia 2008, 13:23-26.
30. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, Ksiazek TG, Mishra A: Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis 2006, 12:235-240.
31. Wong KT, Grosjean I, Brisson C, Blanquier B, Fevre-Montange M, Bernard A, Loth P, Georges-Courbot MC, Chevallier M, Akaoka H et al.: A golden hamster model for human acute Nipah virus infection. Am J Pathol 2003, 163:2127-2137. (Pubitemid 37310041)
32. Marianneau P, Guillaume V, Wong T, Badmanathan M, Looi RY, Murri S, Loth P, Tordo N, Wild F, Horvat B et al.: Experimental infection of squirrel monkeys with Nipah virus. Emerg Infect Dis 2010, 16:507-510.
33. Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP, Wang LF, Mattapallil JJ, Geisbert JB, Bossart KN, Broder CC: Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLoS One 2010, 5:e10690. This study provides an important foundation for subsequent evaluation of vaccine and therapeutics against both Hendra and Nipah viruses in an animal model closest to human infections.
34. Weingartl H, Czub S, Copps J, Berhane Y, Middleton D, Marszal P, Gren J, Smith G, Ganske S, Manning L et al.: Invasion of the central nervous system in a porcine host by Nipah virus. J Virol 2005, 79:7528-7534. (Pubitemid 40756788)
35. Middleton DJ, Westbury HA, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, Hyatt AD: Experimental Nipah virus infection in pigs and cats. J Comp Pathol 2002, 126:124-136.
36. Torres-Velez FJ, Shieh WJ, Rollin PE, Morken T, Brown C, Ksiazek TG, Zaki SR: Histopathologic and immunohistochemical characterization of Nipah virus infection in the guinea pig. Vet Pathol 2008, 45:576-585.
37. Wong KT, Shieh WJ, Kumar S, Norain K, Abdullah W, Guarner J, Goldsmith CS, Chua KB, Lam SK, Tan CT et al.: Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol 2002, 161:2153-2167. (Pubitemid 35434861)
38. Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan YP et al.: A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection. PLoS Pathog 2009, 5:e1000642. First report of a monoclonal antibody therapy that successfully prevented serious Nipah virus disease in a ferret model following lethal challenge.
39. Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, Yamada M, White J, Payne J, Feng YR et al.: A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine 2011, 29:5623-5630. Demonstrates the ability of a subunit vaccine to prevent Hendra virus infection.
40. Hooper P, Zaki S, Daniels P, Middleton D: Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect 2001, 3:315-322. (Pubitemid 32385781)
41. Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT et al.: Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A 2005, 102:10652-10657. (Pubitemid 41061609)
42. Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, Lee B: EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 2005, 436:401-405. (Pubitemid 41059050)
43. Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, Muhlberger E, Su SV, Bertolotti-Ciarlet A, Flick R, Lee B: Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog 2006, 2:e7.
44. Kullander K, Klein R: Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol 2002, 3:475-486. (Pubitemid 34733429)
45. Pager CT, Craft WW Jr, Patch J, Dutch RE: A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology 2006, 346:251-257. (Pubitemid 43357869)
46. Pager CT, Dutch RE: Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J Virol 2005, 79:12714-12720. (Pubitemid 41433191)
47. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE: The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 2004, 101:17264-17269. (Pubitemid 39627808)
48. Rodriguez JJ, Horvath CM: Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling. Viral Immunol 2004, 17:210-219. (Pubitemid 38880422)
49. Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF: Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol 2005, 79:6078-6088. (Pubitemid 40617213)
50. Shaw ML, Garcia-Sastre A, Palese P, Basler CF: Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol 2004, 78:5633-5641. (Pubitemid 38661650)
51. Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, Garcia-Sastre A, Basler CF: Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol 2003, 77:1501-1511. (Pubitemid 36055570)
52. Rodriguez JJ, Cruz CD, Horvath CM: Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J Virol 2004, 78:5358-5367. (Pubitemid 38581486)
53. Virtue ER, Marsh GA, Wang LF: Interferon signaling remains functional during henipavirus infection of human cell lines. J Virol 2011, 85:4031-4034. Highlights the potential of interferon therapy to prevent serious and fatal human Henipavirus disease.
54. Chong HT, Kamarulzaman A, Tan CT, Goh KJ, Thayaparan T, Kunjapan SR, Chew NK, Chua KB, Lam SK: Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol 2001, 49:810-813. (Pubitemid 32530252)
55. RockxB,Bossart KN,Feldmann F, Geisbert JB,Hickey AC,Brining D, Callison J, Safronetz D, Marzi A, Kercher L et al.: A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J Virol 2010, 84:9831-9839.
56. Anonymous: Hendra virus, Equine - Australia (05): (Queensland), Human exposure. ProMED-mail 2010. May 27, 2010, archive no. 20100527.1761.
57. Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D et al.: A neutralizing human monoclonal antibody protects African green monkeys from Hendra virus challenge. Sci Transl Med 2011, 3:105ra103. Building on earlier work of a monoclonal antibody therapy in the ferret model, this study demonstrated an enhanced protection in non-human primates from a fatal Hendra virus challenge.
58. Beilharz MW, Cummins MJ, Bennett AL, Cummins JM: Oromucosal administration of interferon to humans. Pharmaceuticals 2010, 3:323-344.
59. Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, Niezgoda M, Rupprecht C, Bresee J, Breiman RF: Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis 2004, 10:2082-2087. (Pubitemid 39587329)
60. ICDDRB: Nipah encephalitis outbreak over wide area of Western Bangladesh, 2004. Health Sci Bull 2004, 2:7-11.
61. Hanna JN, McBride WJ, Brookes DL, Shield J, Taylor CT, Smith IL, Craig SB, Smith GA: Hendra virus infection in a veterinarian. Med J Aust 2006, 185:562-564. (Pubitemid 44822013)
62. Luby SP, Rahman M, Hossain MJ, Blum LS, Husain MM, Gurley E, Khan R, Ahmed BN, Rahman S, Nahar N et al.: Foodborne transmission of Nipah virus, Bangladesh. Emerg Infect Dis 2006, 12:1888-1894. (Pubitemid 44904927)
63. Arankalle VA, Bandyopadhyay BT, Ramdasi AY, Jadi R, Patil DR, Rahman M, Majumdar M, Banerjee PS, Hati AK, Goswami RP et al.: Genomic characterization of Nipah virus, West Bengal, India. Emerg Infect Dis 2011, 17:907-909.
64. ICDDRB: Person-to-person transmission of Nipah infection in Bangladesh. Health Sci Bull 2007, 5:1-6.
65. Rahman MA, Hossain MJ, Sultana S, Homaira N, Khan SU, Rahman M, Gurley ES, Rollin PE, Lo MK, Comer JA et al.: Date palm sap linked to Nipah virus outbreak in Bangladesh, 2008. Vector Borne Zoonotic Dis 2012, 12:65-72.
66. Anonymous: Hendra virus, Human, Equine - Australia (04): (Queensland) fatal. ProMED-mail 2009. September 3, 2009, archive no. 20090903.3098.
67. ICDDRB: Bangladesh. Nipah outbreak in Faridpur District, Bangladesh, 2010. Health Sci Bull 2010, 8:6-11.
68. Anonymous: Nipah virus, fatal - Bangladesh: (Faridpur). ProMED-mail 2012. February 4, 2012, archive no. 20110204.0402.